Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $2.5 million.

  • Agilon Health's Gains from Investment Securities rose 81213.87% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 70996.88%. This contributed to the annual value of -$887000.0 for FY2024, which is 12193.37% down from last year.
  • Latest data reveals that Agilon Health reported Gains from Investment Securities of $2.5 million as of Q3 2025, which was up 81213.87% from $878000.0 recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Gains from Investment Securities peaked at $2.5 million during Q4 2023, and registered a low of -$2.9 million during Q2 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $365000.0 (2024), whereas its average is $299842.1.
  • The largest annual percentage gain for Agilon Health's Gains from Investment Securities in the last 5 years was 233018.87% (2022), contrasted with its biggest fall of 108588.71% (2022).
  • Quarter analysis of 5 years shows Agilon Health's Gains from Investment Securities stood at $53000.0 in 2021, then soared by 2330.19% to $1.3 million in 2022, then surged by 96.66% to $2.5 million in 2023, then crashed by 154.4% to -$1.4 million in 2024, then surged by 278.81% to $2.5 million in 2025.
  • Its Gains from Investment Securities stands at $2.5 million for Q3 2025, versus $878000.0 for Q2 2025 and $2.2 million for Q1 2025.